发明名称 |
ALKYL [(S)-1-((S)-2-{5-[4-(4-{2-[(S)-1-((S)-2-METHOXYCARBONYLAMINO-3-METHYL-BUTYRYL)-PYRROLIDINE-2-YL]-3H-IMIDAZOLE-4-YL}-BUTA-1,3-DIENYL)-PHENYL]-1H-IMIDAZOLE-2-YL}-PYRROLIDINE-1-CARBONYL)-2-METHYL-PROPYL]-CARBAMATE NAPHTHALENE-1,5-DISULFONATE, PHARMACEUTICAL COMPOSITION, MEDICINAL AGENT AND METHOD FOR TREATMENT OF VIRAL DISEASES |
摘要 |
The present invention relates to NS5A inhibitors, to novel pharmaceutical composition, antiviral medicament, method for prophylaxis and treatment of viral diseases, in particular caused by hepatitis C (HCV) virus and hepatitis GBV-C virus. Alkyl [(S)-1-((S)-2-{5-[4-(4-{2-[(S)-1-((S)-2-methoxycarbonylamino-3-methylbutyryl)-pyrrolidin-2-yl]-3H-imidazol-4-yl}-buta-1,3-diynyl)-phenyl]-1H-imidazol-2-yl}-pyrrolidine-1-carbonyl)-2-methyl-propyl]-carbamate naphthaline-1,5-disulfonate of the general formula 1, possibly in crystalline or polycrystalline form, have been proposed,
wherein: R is C 1 -C 3 alkyl. |
申请公布号 |
EP2955177(A2) |
申请公布日期 |
2015.12.16 |
申请号 |
EP20140749194 |
申请日期 |
2014.02.04 |
申请人 |
IVACHTCHENKO, ALEXANDRE VASILIEVICH;IVASHCHENKO, ANDREY ALEXANDROVICH;SAVCHUK, NIKOLAY FILIPPOVICH |
发明人 |
IVACHTCHENKO, ALEXANDRE VASILIEVICH |
分类号 |
C07C303/32;A61K31/4178;A61P31/12;C07D403/04 |
主分类号 |
C07C303/32 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|